This is TYPE IV damage to human fibroblasts after bleomycin treatment, shown in a 53BP1 stain.
Credit
Bioanalytical Core Laboratory
Usage Restrictions
Bioanalytical Core Laboratory
License
Licensed content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.